Marealis is a Norwegian marine biotechnology B Corporation that was founded in 2008 with a clear mission - to convert by-products into potent bioactive marine peptides that can have a significant effect on blood pressure health. We are committed to finding natural, sustainable, and effective marine-based solutions for blood pressure health, globally. Our goal is to establish Marealis as a global leader in the development, production, and commercialization of natural, sustainable, and effective marine-based health solutions for the world. PreCardix® is an innovative natural health product designed in Norway and made in Canada. Each daily dose of PreCardix® contains 1,200 mg of unique, clinically proven bioactive marine peptides with a documented ACE-inhibiting action. Clinical studies have shown that these unique bioactive marine peptides have a statistically significant effect on blood pressure health and are effective for 89% of adults within eight weeks – without serious side effects. At Marealis, we are committed to sustainability and ensuring that all by-products are repurposed into high-quality shrimp meal powder used in kitchens worldwide. Our sister company, Marealis Innovation AS, further develops marine by-products into new products of higher value. Located in Tromsø, Norway, Marealis is owned by Stella Polaris AS, and our team is dedicated to promoting better health through natural, sustainable, and effective marine-based solutions. Visit www.precardix.com to learn more about PreCardix® and the Marealis commitment to global health.
